BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11298116)

  • 1. Gene expression profile in a case of primary cutaneous CD30-negative large T-cell lymphoma with a blastic phenotype.
    Murakami T; Fukasawa T; Fukayama M; Usui K; Ohtsuki M; Nakagawa H
    Clin Exp Dermatol; 2001 Mar; 26(2):201-4. PubMed ID: 11298116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous pleomorphic T-cell lymphoma expressing CD30 antigen.
    Gianotti R; Alessi E; Cavicchini S; Berti E
    Am J Dermatopathol; 1991 Oct; 13(5):503-8. PubMed ID: 1659246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of CD30+ nasal natural killer/T-cell lymphoma.
    Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
    Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
    Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
    J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
    Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
    Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells].
    Hirsch B; Braun FK; Al-Yacoub N; Assaf C; Kadin ME; Sterry W; Eberle J; Dürkop H
    Pathologe; 2010 Oct; 31 Suppl 2():193-8. PubMed ID: 20812013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extensive cutaneous candidiasis revealing cutaneous T-cell lymphoma: 2 cases].
    Duong T; Ingen-Housz-Oro S; Gaulier A; Petit A; Dubertret L; Sigal-Grinberg M
    Ann Dermatol Venereol; 2006; 133(6-7):566-70. PubMed ID: 16885846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.
    Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R
    Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor-gamma gene analysis of CD30+ large atypical individual cells in CD30+ large primary cutaneous T cell lymphomas.
    Gellrich S; Wilks A; Lukowsky A; Wernicke M; Müller A; Marcus Muche J; Fischer T; Jasch KC; Audring H; Sterry W
    J Invest Dermatol; 2003 Apr; 120(4):670-5. PubMed ID: 12648233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
    Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
    Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD8-positive, CD30-negative cutaneous T-cell lymphoma simulating pyoderma gangrenosum].
    Dueck D; Hermes B; Audring H; Kohl PK
    Hautarzt; 2002 Feb; 53(2):114-7. PubMed ID: 11963190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Cutaneous T-cell Lymphoma With Aberrant CD-20 Expression.
    Karimkhani C; McLaughlin C; Smith C
    J Drugs Dermatol; 2015 May; 14(5):515-6. PubMed ID: 25942672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
    Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
    Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angioimmunoblastic lymphadenopathy-type peripheral T-cell lymphoma with cutaneous infiltration: report of a case and its gene expression profile.
    Murakami T; Ohtsuki M; Nakagawa H
    Br J Dermatol; 2001 Apr; 144(4):878-84. PubMed ID: 11298554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral nervous system involvement in a patient with large T-cell lymphoma arising from a pre-existing mycosis fungoides.
    Peris K; Fargnoli MC; Berardelli A; Crecco M; Tomaselli R; Chimenti S
    Br J Dermatol; 1998 Aug; 139(2):299-301. PubMed ID: 9767248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma.
    Böni R; Xin H; Kamarashev J; Utzinger E; Dummer R; Kempf W; Kutzner H; Burg G
    J Invest Dermatol; 2000 Dec; 115(6):1104-7. PubMed ID: 11121148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
    Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma.
    Chang SE; Park IJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Br J Dermatol; 2000 Apr; 142(4):766-70. PubMed ID: 10792229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.